Dr. Matt Johnson Explains Why SSRIs Are 'Band-Aid Solutions' for PTSD

Описание: SSRIs function as "band-aid solutions" for PTSD while MDMA therapy addresses root causes, according to our discussion

The statistics: "SSRIs achieve full remission in only 20-30% of PTSD patients after 8-12 weeks, with 50-60% showing partial response"

The comparison: "MDMA treatments are much more holistic, identifying root cause and helping people process trauma rather than SSRIs being more of a band-aid solution"

Dr. Johnson's assessment: "I believe it was a majority in remission with MDMA - a higher percentage than SSRIs, which is part of why it got breakthrough designation"

The key mechanism Dr. Johnson explained: "People are making psychological insights and therapeutic gains during the drug treatment that persist in the same way that a course of psychotherapy can persist"

The difference: MDMA therapy enables patients to process underlying trauma through lasting therapeutic insights, while SSRIs primarily manage symptoms without addressing root causes

The regulatory failure: FDA rejected MDMA therapy despite superior outcomes, leaving PTSD patients dependent on less effective treatments

FULL INTERVIEW - LINK IN BIO

Should trauma treatment prioritize symptom management or root cause processing?

#RavArora #DrMattJohnson #MDMA #PTSD #SSRIs #FDA #MentalHealthCrisis #TraumaTherapy #PsychedelicTherapy #RootCause